- Exhibit & Support
- Travel & Hotels
New treatments for chronic obstructive pulmonary disease (COPD)—including monotherapy and combination agents approved by the U.S. Food and Drug Administration—raise questions for pharmacists about when and where to put these therapies to most effective use. In this interactive session, experts will use real-world cases to share practical approaches on how to assess patients with COPD. With a comparison of old versus new therapies, you will leave with the practical skills needed to manage patients in both inpatient and outpatient settings.
Select Intensive Studies for Recertification 2018 when you register for APhA2018 to purchase the intensive studies exam for BPS recertification credit. Cost: $50.00
At the completion of this application-based activity, participants will be able to:
This activity is approved for board-certified ambulatory care pharmacist (BCACP) recertification credit.